Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon-alpha-induced psoriasis vulgaris]

L U Wölfer1, S Goerdt, K Schröder

  • 1Hautklinik und Poliklinik, Freie Universität, Berlin.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|February 1, 1996
PubMed
Summary

Systemic interferon-alpha therapy can trigger or worsen psoriasis and psoriatic arthritis. Discontinuation of the drug often leads to symptom resolution, highlighting the need for careful risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Epidemiology and treatment of Adamantiades-Behçet's disease in Germany: A healthcare claims database study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Age-associated metastatic potential of melanoma in lymph nodes: A preliminary gene association study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Significant spontaneous daily fluctuation of inflammatory nodules and abscesses but not of draining tunnels in hidradenitis suppurativa/acne inversa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Premature skin ageing signs due to androgen deprivation therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Late-onset Adamantiades-Behçet's disease-systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

  • Dermatology
  • Immunology
  • Oncology

Background:

  • Interferon-alpha is a common systemic therapy for cancers and viral infections.
  • Known side effects include skin dryness, itching, and hair loss.

Observation:

  • Psoriasis development or exacerbation occurred in patients receiving interferon-alpha for various conditions.
  • Three new cases are presented, treated for HIV-associated Kaposi's sarcoma, renal cell carcinoma, and hepatitis C.

Findings:

  • Systemic interferon-alpha can induce or exacerbate psoriatic skin and joint symptoms.
  • Psoriatic lesions resolved in most patients after drug discontinuation.
  • Recurrence of psoriasis was noted in some patients upon re-challenge or continued therapy.

Related Experiment Videos

Implications:

  • Interferon-alpha therapy requires careful benefit-risk assessment in patients predisposed to psoriasis.
  • Concomitant antipsoriatic treatments may be necessary for patients continuing interferon-alpha.
  • Understanding interferon's role in psoriasis pathogenesis is crucial for managing treatment side effects.